Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Twist Bioscience Corp

Get SEC filing alerts via email and in your feed for Twist Bioscience Corp

TWST

Twist Bioscience Corp

About Twist Bioscience Corp

Twist Bioscience specializes in synthetic DNA and RNA manufacturing using proprietary silicon-based platform technology. Its core products include synthetic genes, oligonucleotide pools, NGS tools, and antibody libraries, serving global research, healthcare, and industrial markets. The company enables applications in drug discovery, diagnostics, materials, agriculture, and data storage, offering high-quality, scalable, and cost-effective solutions with a focus on innovation, sustainability, and regulatory compliance.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Twist Bioscience Corp

1
1
Twist Bioscience Corp Twist Bioscience Reports 19.3% Revenue Growth in Q2 Fiscal 2026 Despite Increased Net Loss

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
Twist Bioscience Corp Twist Bioscience Reports 16.9% Revenue Growth to $103.7 Million in Q1 Fiscal 2026

Via official filing (AI summary) | 4 months ago | 0 comments

3
1
Twist Bioscience Corp Twist Bioscience Reports 20% Revenue Growth to $376.6 Million for Fiscal Year Ending September 30, 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Twist Bioscience Corp Twist Bioscience Reports 18% Revenue Growth and Net Income Turnaround in Latest Quarter

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Twist Bioscience Corp Twist Bioscience Reports 23% Revenue Growth to $92.8 Million in Q2 FY 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Twist Bioscience Corp Twist Bioscience Reports 24% Revenue Growth to $88.7 Million in Q1 Fiscal 2025

Via official filing (AI summary) | over 1 year ago | 0 comments